Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Direct Oral Anticoagulant Levels in Chinese Patients With Atrial Fibrillation - A Real- World Pharmacokinetic Study

NCT05378035 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

NCT NCT05378035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05378035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Direct Oral Anticoagulant Levels in Chinese Patients With Atrial Fibrillation - A Real- World Pharmacokinetic Study
Lead sponsor
Chinese University of Hong Kong
Phase
Observational
Overall status
Recruiting
Start date
September 28, 2022
Completion date
December 31, 2027
Enrollment
427 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arterial thromboembolism, atrial fibrillation, brain diseases, major adverse cardiovascular event, stroke, stroke, acute, venous thromboembolism